# Zoetic International partner with cannabinoid research experts GVB Biopharma

- Link: https://www.directorstalkinterviews.com/zoetic-international-partner-with-cannabinoid-research-experts-gvb-biopharma/412844908
- Published: 2020-07-22T07:32:27+01:00
- Author: Giles Arbor

**Zoetic International plc **(LON:ZOE) has provided the following hemp seed update.

**Highlights**

·  Expansion of the Company’s seed testing programme as partnership agreed with 
specialist firm GVB Biopharma.

·    Termination of the lease for the Company’s Colorado production facility, reducing
high ongoing costs.

·    Joint Venture established with a European partner to establish a new base for
cultivating the Company’s high quality hemp seeds.

**Expansion of seed testing programme**

Zoetic is pleased to announce a partnership with cannabinoid research experts GVB
Biopharma. The Company is confident in the value and strong cultivation potential
of its seeds, and with its ongoing commitment to ensuring the highest quality products
is now taking the additional step of verifying the quality of its base CBD assets
through measurable channels.

With a bank of 40,000 feminized hemp seeds already under the care of GVB, planted
in USDA certified ground, this growing season presents an opportunity to gather 
extensive data relating to their cultivation viability, along with the production
of high-calibre CBD isolate. With Zoetic’s seed stock due to be cultivated and tested
in outdoor facilities, this represents the first large scale commercial hemp study
and is a landmark achievement for the Company in its efforts to validate its genetic
base.

Armed with the commercial intelligence generated both from GVB’s research and the
continuation of the existing testing programme by US universities, Zoetic will be
well placed to accelerate its ongoing global product rollout whilst avoiding the
reported difficulties faced by certain Kentucky and North Carolina based competitors
with what appears to be genetically deficient hemp seed stocks.

> **Antonio Russo, Co-CEO of Zoetic, commented**, “We are thrilled to have contracted
> with GVB Biopharma to conduct large-scale testing of our hemp seed stock. With
> the CBD industry becoming increasingly litigious, now is not the time to make 
> uninformed business decisions and we strongly believe that by entering into this
> partnership, Zoetic will be better positioned to take data-driven action to move
> the Company and its products forward.”

**End of Colorado facility leasehold**

Owing to the ongoing development and evolution of Zoetic’s business model, the Company
will be terminating its leasehold agreement for its Colorado greenhouse facility.
The acquisition of the Lease was finalised when the Company was trading as Highlands
Natural Resources plc and the transition away from that facility is representative
of Zoetic’s continued commitment to the transformation and advancement of its CBD
operations. 

As Chill, Zoetic’s tobacco alternative brand, continues to grow and evolve, the 
Board recognises the need for the Company to maintain its scalability in line with
both development and demand. Movement away from the Company’s historical premises
will help to facilitate its reformation towards more agile and versatile business
practices through partnerships with third party cultivators.

> **Trevor Taylor, Co-CEO of Zoetic, commented**, “As our Chill products enjoy sustained
> growth in their popularity, now is the right time to modernise the Company’s infrastructure
> and bring production into line with our vision. Although our facility in Colorado
> has served us well, we look forward to the new opportunities that other global
> cultivation sites offer whilst reducing one of the Company’s most significant 
> overhead costs.”

**Establishment of a European Joint Venture for genetics cultivation and distribution**

As the Company winds down operations at its Colorado facility, Zoetic is pleased
to announce that an agreement has been reached for a new Joint Venture with a trusted
European cultivation partner. Having already developed a firm presence within the
UK CBD market and recently signed its first European distribution agreement, the
Company is enthusiastic to continue its growth within the region whilst drawing 
on the agronomy expertise of its JV partner to establish a new base for cultivating
its high-calibre hemp seeds.

Zoetic’s movement of growing operations to Europe is accompanied by a renewed commitment
to strengthen the attraction of its offering within the European market, whilst 
utilising the UK’s position as an international distribution hub to continue with
the formation of new distribution channels across Europe and beyond.

Through strong collaboration between Zoetic and the JV partner, the Board is confident
that the genetics division is well placed to develop its presence within the European
market whilst navigating any regulatory requirements in the emerging hemp growing
industry. With correct market positioning and appropriate legal protections in place,
there is scope for Zoetic to be a leading UK/EU provider of high calibre hemp seed
genetics.

> **Trevor Taylor, Co-CEO of Zoetic International, commented,** _“This joint venture
> is the first step in the Company’s expansion into the global markets with its 
> seed genetics._  _With the movement of seed cultivation operations to Europe, 
> Zoetic is set to scale the growth of its seed offerings as field trials in the
> US are completed.”_

Share on:
